0001225208-21-013112.txt : 20211015 0001225208-21-013112.hdr.sgml : 20211015 20211015161610 ACCESSION NUMBER: 0001225208-21-013112 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211014 FILED AS OF DATE: 20211015 DATE AS OF CHANGE: 20211015 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DIMON JAMES CENTRAL INDEX KEY: 0001195345 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-05805 FILM NUMBER: 211326246 MAIL ADDRESS: STREET 1: 270 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JPMORGAN CHASE & CO CENTRAL INDEX KEY: 0000019617 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 132624428 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 383 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2122706000 MAIL ADDRESS: STREET 1: 383 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: J P MORGAN CHASE & CO DATE OF NAME CHANGE: 20010102 FORMER COMPANY: FORMER CONFORMED NAME: CHASE MANHATTAN CORP /DE/ DATE OF NAME CHANGE: 19960402 FORMER COMPANY: FORMER CONFORMED NAME: CHEMICAL BANKING CORP DATE OF NAME CHANGE: 19920703 4 1 doc4.xml X0306 4 2021-10-14 0000019617 JPMORGAN CHASE & CO JPM 0001195345 DIMON JAMES 383 MADISON AVENUE NEW YORK NY 10179-0001 1 1 Chairman & CEO Common Stock 2021-10-14 4 M 0 562430.0000 35.6100 A 912186.0000 D Common Stock 2021-10-14 4 F 0 375403.0000 162.0350 D 536783.0000 D Common Stock 8107.9426 I By 401(k) Common Stock 2097090.0000 I By Family Trusts Common Stock 4828594.0000 I By GRATs Common Stock 152940.0000 I By LLC Common Stock 871766.0000 I By Spouse Stock Appreciation Rights 35.6100 2021-10-14 4 M 0 562430.0000 0.0000 D 2022-01-18 Common Stock 562430.0000 0.0000 D Reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest. Exercise of SARs pursuant to 10b5-1 Plan dated August 9, 2021 Stock appreciation rights granted on January 18, 2012, which have a ten-year term, became exercisable in five equal installments beginning January 18, 2013. Shares resulting from exercise must be held at least five years from the grant date. /s/ David K.F. Gillis under POA 2021-10-15